Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes
Status: | Recruiting |
---|---|
Conditions: | Asthma |
Therapuetic Areas: | Pulmonary / Respiratory Diseases |
Healthy: | No |
Age Range: | 5 - 11 |
Updated: | 4/21/2016 |
Start Date: | March 2015 |
End Date: | February 2017 |
Contact: | Jerry A Krishnan, MD, PhD |
Email: | jakris@uic.edu |
Phone: | 312-413-0637 |
Coordinated Healthcare Interventions for Childhood Asthma Gaps in Outcomes (CHICAGO Trial)
Chicago is an epicenter for asthma health disparities in the U.S., with African-American
children 5-11 yrs bearing a disproportionate share of the burden. Among the most visible of
these disparities is the high rate of visits to the Emergency Department (ED) for
uncontrolled asthma. Clinical uncertainties regarding the real-world effectiveness of
guideline recommendations for ED discharge and strategies to reduce environmental triggers
at home contribute to practice variation and poor adherence to guidelines. The CHICAGO Trial
tests both ED- and home-level interventions to improve clinically meaningful outcomes in a
minority pediatric ED population with uncontrolled asthma.
children 5-11 yrs bearing a disproportionate share of the burden. Among the most visible of
these disparities is the high rate of visits to the Emergency Department (ED) for
uncontrolled asthma. Clinical uncertainties regarding the real-world effectiveness of
guideline recommendations for ED discharge and strategies to reduce environmental triggers
at home contribute to practice variation and poor adherence to guidelines. The CHICAGO Trial
tests both ED- and home-level interventions to improve clinically meaningful outcomes in a
minority pediatric ED population with uncontrolled asthma.
Inclusion Criteria:
- Age: 5-11 years at date of ED visit
- Seen at participating ED
- Attending physician clinical diagnosis of asthma exacerbation
- Treatment with at least 1 dose short acting bronchodilator (beta2 agonist or
anticholinergic)
- Treatment with at least 1 dose systemic corticosteroids (oral, IV or IM)
- Receiving treatment for asthma in ED and/or observation unit for at least 1 hour
- Attending physician indicates that patient is likely (>75% chance) to be discharged
to home directly from ED or observation unit.*
- Primary language: English or Spanish
Exclusion Criteria:
- Patient admitted to the hospital
- Discharge location other than home (e.g., other hospital)
- Caregiver unable or declines to provide written permission or informed consent prior
to discharge to home
- Child or other member of household is current/previous participant in the CHICAGO
Trial
- Concurrent enrollment in other asthma research or enrolled in a different Community
Health Worker (CHW) home visit program.
- Plan to move away from study site in next 12 months.
We found this trial at
6
sites
5801 South Ellis Avenue
Chicago, Illinois 60637
Chicago, Illinois 60637
773.702.1234
Phone: 773-702-5170
University of Chicago One of the world's premier academic and research institutions, the University of...
Click here to add this to my saved trials
Click here to add this to my saved trials
225 E Chicago Ave
Chicago, Illinois 60611
Chicago, Illinois 60611
(312) 227-4000
Phone: 312-227-6010
Ann & Robert H. Lurie Children's Hospital of Chicago Ann & Robert H. Lurie Children
Click here to add this to my saved trials
Click here to add this to my saved trials
1653 W. Congress Parkway
Chicago, Illinois 60612
Chicago, Illinois 60612
(312) 942-5000
Phone: 312-942-8571
Rush University Medical Center Rush University Medical Center encompasses a 664-bed hospital serving adults and...
Click here to add this to my saved trials
2035 W Taylor St
Chicago, Illinois
Chicago, Illinois
(312) 996-4350
Phone: 312-413-1655
University of Illinois at Chicago A major research university in the heart of one of...
Click here to add this to my saved trials